Accolade (ACCD) Scheduled to Post Quarterly Earnings on Thursday

Accolade (NASDAQ:ACCDGet Free Report) is scheduled to issue its quarterly earnings data after the market closes on Thursday, April 25th. Analysts expect the company to announce earnings of ($0.11) per share for the quarter. Parties interested in listening to the company’s conference call can do so using this link.

Accolade Stock Up 1.5 %

Shares of NASDAQ:ACCD opened at $9.35 on Wednesday. Accolade has a 1 year low of $6.33 and a 1 year high of $17.00. The business has a 50 day simple moving average of $9.90 and a two-hundred day simple moving average of $9.92. The firm has a market capitalization of $723.78 million, a PE ratio of -5.67 and a beta of 2.08. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.35 and a quick ratio of 2.35.

Analysts Set New Price Targets

Several research analysts have issued reports on ACCD shares. Stifel Nicolaus dropped their target price on Accolade from $15.00 to $13.00 and set a “buy” rating for the company in a research report on Monday. Piper Sandler boosted their price target on Accolade from $12.00 to $15.00 and gave the company an “overweight” rating in a report on Tuesday, January 9th. Needham & Company LLC reiterated a “buy” rating and issued a $17.00 price target on shares of Accolade in a report on Friday, January 19th. Wells Fargo & Company boosted their price target on Accolade from $10.00 to $12.00 and gave the company an “equal weight” rating in a report on Tuesday, January 9th. Finally, SVB Leerink started coverage on shares of Accolade in a research note on Monday, February 26th. They issued an “outperform” rating and a $16.00 price objective for the company. Four analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $15.53.

Check Out Our Latest Stock Analysis on ACCD

Accolade Company Profile

(Get Free Report)

Accolade, Inc, together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians.

Further Reading

Earnings History for Accolade (NASDAQ:ACCD)

Receive News & Ratings for Accolade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accolade and related companies with MarketBeat.com's FREE daily email newsletter.